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KEYWORDS	
	 The	 sulfonamide	 derivative,	 4‐((3‐formyl‐4‐hydroxyphenyl)diazenyl)‐N‐(4‐methyloxazol‐2‐
yl)	benzenesulfonamide	 (FDMB),	was	synthesized	and	characterized.	Additionally,	 its	Cu(II),
Co(II),	 Ni(II),	 Mn(II)	 and	 Fe(III)	 complexes	 were	 prepared	 and	 their	 structures	 were
investigated	 by	 elemental	 analysis,	 thermal	 analysis	 and	 (IR,	 electronic	 and	 EPR)
spectroscopy.	The	mode	of	 binding	 indicates	 that	 the	 ligand	binds	 to	 the	metal	 ion	 through
carbonyl	 oxygen	 and	OH	phenolic	with	 displacement	 of	 its	 proton.	 The	 Co(II)	 complex	was
applied	 for	 the	 hydrolysis	 of	 nerve	 agent‐like	 compound,	 bis‐(p‐nitrophenyl)	 phosphate
(BNPP).	The	results	showed	a	significant	rate	enhancement	of	2.5	million	fold	with	respect	to
the	auto‐hydrolysis	of	BNPP	under	the	same	conditions.	
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1.	Introduction	
	
Sulfonamide	moiety	has	a	vital	 functionality	because	of	 its	
wide	varieties	of	reported	biological	[1,2]	and	pharmacological	
activities	 such	 as	 anticancer	 [3,4],	 carbonic	 anhydrase	
inhibitory	 [5,6],	 antibacterial	 [7,8],	 antimalarial	 [9],	 antitumor	
[10],	 antihypertensive	 [11],	 and	 anti‐inflammatory	 [12].	
Sulfonamide	has	been	also	reported	to	possess	good	herbicidal	
[13]	 and	 corrosion	 inhibitory	 properties	 [14,15].	 At	 the	 same	
time,	 N‐salicylideneamino	 acidato	 metal	 complexes	 with	
different	 organic	 ligands	 have	 been	 prepared,	 characterized	
[16‐18]	 then	 the	 chemical	 nuclease	 property	 of	 these	 metal	
complexes	 that	 intercalates	 into	 the	 DNA	 grooves	 [19]	 have	
been	 introduced.	 Some	 ternary	 salicylaldehyde‐amino	 acid	
Schiff	 base	 complexes	 of	 Cu(II)	with	 1,10‐phenanthroline	 and	
2,2ʹ‐bipyridine	 exhibit	 antitumor	 activity	 as	 tumor	 chemo‐
therapeutic	 agents	 and	 tumor	 radio‐imaging	 [20].	 It	 is	 well	
known	that	 the	phosphoester	bond	 is	considered	as	backbone	
of	 the	 pesticides	 and	 nerve	 agents.	 Hydrolytic	 chemistry	 can	
play	 very	 important	 role	 in	 degradation	 of	 phosphoester	
pesticides	and	nerve	agents,	 including	the	G‐agents	(Sarin	and	
Salman)	 and	 the	 VX‐agent	 [21].	 Recent	 efforts	 to	 design	
synthetic	 metalloenzymes	 and	 elucidate	 the	 mechanisms	 by	
which	 metal	 ions	 promote	 hydrolysis	 have	 focused	 primarily	
on	metal	 complexes	 [22].	A	 large	number	of	metal	 complexes	
have	 been	 synthesized	 in	 recent	 years	 as	 models	 of	
metallohydrolases,	 for	 the	 purpose	 of	 effective	 hydrolysis	 of	
phosphoesters	 such	 as	 DNA	 and	 nerve	 agent‐like	 compounds	
[23,24].		
In	this	study,	we	prepared	and	characterized	4‐((3‐formyl‐
4‐hydroxyphenyl)diazenyl)‐N‐(4‐methyloxazol‐2‐yl)	 benzene	
sulfonamide	 and	 its	metal	 complexes.	 The	 Co(II)	 complex	has	
been	 used	 as	 heterogeneous	 catalyst	 on	 the	 hydrolysis	 of	
phosphodiesters	bis‐(p‐nitrophenyl)phosphate	as	a	nerve	agent	
like	compound.	
	
2.	Experimental	
	
2.1.	Physical	measurements	
	
Cu(II),	 Co(II),	 Ni(II),	 Mn(II)	 and	 Fe(III)	 ions	 were	
determined	 by	 complexometric	 titration	 using	 xylenol	 orange	
as	 indicator	 [25,26].	 Carbon,	 hydrogen	 and	 nitrogen	 contents	
were	determined	at	 the	Microanalytical	Unit,	Cairo	University,	
Egypt.	 IR	 spectra	 of	 the	 ligand	 and	 its	 solid	 complexes	 were	
recorded	 in	 KBr	 disc	 on	 a	Mattson	 5000	 FT‐IR	 spectrometer.	
The	 electronic	 spectra	 of	 the	 ligand	 and	 its	 solid	 complexes	
were	recorded	in	DMSO	in	UV/Vis	range	(195‐1100)	nm	using	
Perkin	 Elmer	 Lambda	 35	 UV/Vis	 Spectrometer.	 Magnetic	
moments	were	determined	using	a	Johnson	Matthey	balance	at	
room	 temperature	 (25	 °C)	 with	 Hg[Co(NCS)4]	 as	 a	 calibrant.	
The	diamagnetic	corrections	for	the	ligand	and	the	metal	atoms	
were	computed	using	Pascal's	constants	[27].	Thermal	analysis	
measurements	 TGA	 were	 recorded	 on	 a	 Shimadzu	 thermo‐
gravimetric	 analyser	 model	 TGA‐50H,	 using	 20	 mg	 samples.	
The	flow	rate	of	nitrogen	gas	and	heating	rate	was	20	mL/min	
and	10	°C/min,	respectively.		
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Table	1.	Physical	properties	and	elemental	analysis	of	the	synthesized	metal	complexes.	
Complex	 M.wt,	g	 Color	 Yield,	% Melting	point,	oC %C
Calcd./Found	
%H
Calcd./Found	
%N	
Calcd./Found	
%M
Calcd./Found	
Cu(L‐H)2(H2O)3	 887	 Bluff	 72	 >300	 45.9/45.9	 3.6/4.3	 12.6/12.2	 7.1/7.5	
Mn(L‐H)2	(H2O)6	 931	 Brown	 65	 >300	 43.8/43.6	 4.1/3.3	 12.0/11.4	 5.9/6.3	
CoL‐H	(Ac)MeOH.3H2O	 589	 Brown	 75	 >300	 40.7/41.5	 4.4/4.0	 9.5/10.3	 10.0/10.5	
NiL‐H	(Ac)MeOH.1.5H2O	 562	 Brown	 73	 >300 42.7/42.7 4.1/4.2 9.9/10.2	 10.5/10.0
FeL‐H	(OH)2(H2O)2	 511	 Black	 70	 176 39.9/40.1 3.7/3.8 10.9/10.9	 10.9/11.0
	
	
The	 1H	 NMR	 spectra	 were	 recorded	 in	 DMSO‐d6	 using	
ovarian	 FT‐300	 MHz	 spectrometer	 using	 TMS	 as	 internal	
standard.	The	mass	spectrum	of	 the	 ligand	was	recorded	on	a	
Shimadzu	 GC‐S‐QP	 1000	 EX	 spectrometer	 using	 a	 direct	 inlet	
system.	 The	 kinetic	 measurements	 for	 hydrolysis	 of	
phosphodiester	 were	 performed	 using	 Perkin	 Elmer	 Lambda	
35	UV/Vis	Spectrometer.		
	
2.2.	Synthesis	of	4‐((3‐formyl‐4‐hydroxyphenyl)diazenyl)‐N‐
(4‐methyloxazol‐2‐yl)benzenesulfonamide	(FDMB)	
	
Sulfamethoxazole	 (0.01	mol)	was	mixed	with	HCl	 (10	mL)	
and	water	 (16	mL)	 and	 then	digested	 on	 a	water	 bath	 for	 30	
min.	 The	 sulfamethoxazole	 hydrochloride	 was	 cooled	 to	 5	 oC	
and	 diazotized	with	 ice‐cold	 aqueous	NaNO2	 solution	 (5	 g,	 20	
mL).	A	cold	solution	of	salicylaldehyde	(0.01	mol)	dissolved	in	
10%	NaOH	solution	(50	mL)	was	added	to	the	cold	diazonium	
salt	 solution	 with	 vigorous	 stirring.	 A	 red	 colour	 developed	
immediately	 and	 the	 stirring	 was	 continued	 for	 1	 h.	 The	
reaction	mixture	was	kept	overnight	in	a	refrigerator,	followed	
by	 3	 h	 at	 room	 temperature,	 and	 then	 acidified	 with	 dilute	
acetic	 acid.	 The	 yellow	 orange	 precipitate	 separated	 out.	 The	
precipitate	 was	 filtered,	 washed	 several	 times	 with	 water	 to	
remove	 excess	 acetic	 acid	 and	 water‐soluble	 materials,	 and	
finally	dried	in	air.	The	crude	product	was	washed	with	hexane	
to	 remove	 any	 tarry	 materials,	 dried	 in	 vacuum	 and	
recrystallized	from	methanol	to	yield	yellow	prismatic	crystals	
of	Ligand	FDMB.		
4‐((3‐Formyl‐4‐hydroxyphenyl)diazenyl)‐N‐(4‐methyloxazol‐
2‐yl)benzenesulfonamide	 (FDMB):	 Color:	 Light	 brown.	 Yield:	
70%.	M.p.:	204	oC.	FT‐IR	(KBr,	,	cm‐1):	3072	(OH),	1658	(C=O),	
1614	(C=N),	1401	(SO2),	3420	(NH),	1476	(N=N).	1H	NMR	(300	
MHz,	 DMSO‐d6,	 δ,	 ppm):	 2.31	 (s,	 3H,	 CH3),	 6.19	 (s,	 1H,	 CH‐
oxazole),	 7.20‐8.03	 (m,	 7H,	 Ar‐H),	 8.22	 (s,	 1H,	 CHO),	 10.37	
(s,1H,	NH),	11.64	(s,	1H,	OH).	MS	(EI,	m/z	(%)):	386	(M+,	12).		
	
2.3.	Preparation	of	metal	complexes	
	
Metal	 chlorides	 (Fe(III)	 and	 Mn(II))	 or	 metal	 acetates	
(Cu(II),	 Co(II),	 Ni(II))	 (1.0	 mmol)	 were	 dissolved	 in	 ~60	 mL	
methanol.	This	solution	was	added	dropwise	 to	(0.2	mmol)	of	
the	 ligand	 dissolved	 in	 ~40	 mL	 methanol	 with	 continues	
stirring.	The	mixture	was	heated	under	reflux	for	2.0	hrs.	The	
precipitate	 was	 formed	 and	 filtered	 off,	 washed	 with	 diethyl	
ether	and	finally	dried	in	an	open	air.	The	physical	properties	of	
the	metal	complexes	are	listed	in	Table	1.	
	
2.4.	Kinetic	reactions	for	phosphoester	hydrolysis	
	
The	 hydrolytic	 reaction	 was	 performed	 using	 solid	
complexes	 as	 heterogeneous	 catalysts	 in	 50	 mL	 of	 N‐2‐
hydroxyethylpiperazine‐N’‐2‐ethanesulfonic	 acid	 (HEPES)	
buffer	 solution	 (50	 mmol,	 pH	 =	 8.0).	 The	 substrate	 bis‐(p‐
nitrophenyl)	 phosphate	 (BNPP),	 dissolved	 in	 50	 mmol	 of	
HEPES	 buffer	 solution	 (pH	 =	 8.0)	 was	 added	 to	 the	 previous	
solution.	The	heterogeneous	mixture	has	been	 stirred	using	 a	
magnetic	 stirrer.	 The	 mixture	 was	 centrifuged	 and	 the	
absorbance	 of	 the	 supernatant	 has	 been	 measured	 using	
spectrophotometer	 at	 405	 nm.	 The	 increase	 in	 absorbance	 at	
405	nm	was	followed	with	time.		
The	reference	cell	 contains	substrate	without	 the	complex	
has	 been	 used	 to	 correct	 the	 background	 hydrolysis.	
Experiments	were	repeated	three	times	to	ensure	accuracy.		
	
3.	Results	and	discussion		
	
The	structure	of	the	organic	ligand	FDMB	was	elucidated	on	
the	 basis	 of	 its	 analytical	 and	 spectral	 data.	 The	 infrared	
spectrum	 of	 FDMB	 reveals	 absorption	 bands	 at	 1658,	 1476,	
1401	and	1614	cm‐1	corresponding	to	νC=O,	νN=N,	νSO2,	and	νC=N,	
respectively.	The	1H	NMR	of	this	compound	showed	signal	at	δ	
2.31	(s,	3H,	CH3),	6.19	(s,	1H,	CH‐oxazole),	7.20‐8.03	(m,	7H,	Ar‐
H),	8.22	(s,	1H,	CHO),	10.37	(s,	1H,	NH)	and	11.64	(s,	1H,	OH).	
All	these	data	together	with	the	mass	spectrum	which	showed	a	
molecular	 ion	peak	at	m/z	=	386,	and	base	peak	at	m/z	=	121	
suggest	the	proposed	structure	of	the	ligand	FDMB	(Scheme	1).		
	
S
O
ONH
O
N
N
N
OH
O
	
	
4‐((3‐Formyl‐4‐hydroxyphenyl)diazenyl)‐N‐(4‐methyloxazol‐2‐yl)benzene	
sulfonamide	(FDMB).	
	
Scheme	1	
	
3.1.	IR	spectra		
	
By	 comparing	 the	 IR	 spectral	 data	 of	 the	 ligand	 and	 their	
metal	 ion	complexes,	one	finds	that	the	whole	metal	 ions	bind	
to	 the	 organic	 ligand	 through	 phenolic	 OH	 group	 with	 the	
liberation	 of	 its	 hydrogen	 atom	 and	 the	 oxygen	 atom	 of	 the	
aldehydic	 group.	 This	 assumption	 is	 supported	 by	
disappearance	of	the	νOH	band	which	was	appeared	at	3072	cm‐
1.	At	the	same	time	the	carbonyl	band	νCO	was	shifted	to	higher	
wavenumber.	 Both	 Co	 and	 Ni	 complexes	 have	 two	 bands	 at	
(1320‐1340)	 and	 (1515‐1520)	 cm‐1	 corresponding	 to	 acetate	
group	 νsymCOO	 and	 νasymCOO.	 On	 the	 other	 hand	 the	 negative	
test	 for	 the	 chloride	 ion	 in	 the	 iron	 complex	 indicates	 the	
liberation	 of	 two	 chloride	 ions	 with	 the	 formation	 of	 two	
hydroxo	 Fe3+	 compound	 due	 to	 a	 partial	 hydrolysis	 of	 FeCl3.	
The	band	observed	at	950	cm‐1	which	is	obscured	in	the	spectra	
of	the	ligand	and	the	above	mentioned	complexes	may	attribute	
to	 OH	 hydroxo	 [28].	 The	 proposed	 structures	 also	 were	
supported	by	existence	of	C=N,	SO2,	NH	and	N=N	bands	at	their	
positions	 in	 the	 ligand	 spectrum	 without	 changes	 (Table	 2)	
which	 indicate	 that	 these	 functional	 groups	 are	 not	
participating	in	the	binding.	The	band	appears	at	(3480‐3490)	
cm‐1	was	attributed	to	water	molecules	in	all	metal	complexes.	
The	mode	of	binding	in	these	metal	complexes	reveals	that	the	
copper	 and	manganese	 coordinate	 to	 the	 ligand	 FDMB	 in	 the	
ratio	of	1:2	(M:L)	where	M	=	Cu	or	Mn	and	L	=	FDMB.	Whereas	
the	 coordination	 of	 the	 cobalt,	 nickel	 and	 iron	 complexes	 are	
founded	to	be	in	the	mole	ration	of	1:1	(M:L).	
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Table	2.	IR	bands	of	the	ligand	and	its	metal	complexes.	
Compound	 νC=O νC=N νN=N νC‐O νSO2	 νNH
Ligand	 1658 1614 1476 1092 1401	 3420
Cu(L‐H)2(H2O)3	 1795 1611 1471 1103 1398	 3423
Mn(L‐H)2	(H2O)6	 1795 1618 1467 1109 1396	 3424
CoL‐H	(Ac)MeOH.	3H2O	 1791 1620 1468 1101 1398	 3423
NiL‐H	(Ac)MeOH.	1.5H2O	 1865 1616 1474 1101 1397	 3421
FeL‐H	(OH)2(H2O)2	 1796 1618 1468 1109 1397	 3419
	
	
		
3.2.	Electronic	and	EPR	spectra		
	
The	 electronic	 spectrum	 of	 [CoL‐H	 (Ac)MeOH].3H2O	
complex	 shows	 two	 bands	 at	 380	 and	 453	 nm	 assignable	 to	
4T1g(f)	 →	 4A2g(f)	 transitions	 The	 magnetic	 moment	 value	 4.5	
B.M.	 is	 in	conformity	with	tetrahedral	structure.	The	magnetic	
moment	 measurement	 of	 the	 Ni(II)	 complex	 [NiL‐H	
(Ac)MeOH].1.5H2O	at	room	temperature	shows	that	the	nickel	
complex	is	a	diamagnetic.	The	band	appears	at	450	nm	with	the	
diamagnetic	nature	corresponding	to	a	square	planar	geometry	
around	 the	 Ni(II)	 ion.	 The	 manganese	 complex	 [Mn(L‐
H)2](H2O)6	shows	intense	absorption	band	at	340	nm	assigned	
to	 ligand	 centered	 transition	 while	 two	 weak	 transitions	 are	
observed	 at	 375	 nm	 and	 460	 nm	 may	 be	 referred	 to	 a	
combination	of	MLCT	and	d‐d	 transition	(4A1→4T1),	suggesting	
tetrahedral	 geometry	 of	 the	 complex.	 The	 magnetic	 moment	
value	of	the	manganese(II)	complex	5.6	BM	may	also	support	a	
high	spin	tetrahedral	complex	[29].	The	magnetic	moment	(1.9	
BM)	 of	 the	 Cu(II)	 complex	 [Cu(L‐H)2](H2O)3	 at	 room	
temperature	 corresponds	 to	 one	 unpaired	 electron	 [30].	 The	
electronic	 spectrum	 of	 the	 copper	 (II)	 complex	 recorded	 in	
ethanol	 reveals	an	absorption	band	at	495	nm.	This	 band	can	
be	 attributed	 to	 d‐d	 transition	 (2B1g→2A1g),	 which	 supports	
square‐planar	geometry	around	the	metal	 ion	[31].	The	bands	
at	 280	 and	 370	 nm	 can	 be	 assigned	 to	 a	 CT	 band	 from	 filled	
orbitals	Cu(II)	to	the	anti‐bonding	π*	orbitals	of	the	ligand	[32].	
The	 EPR	 spectrum	 of	 the	 complex	 [Cu(L‐H)2](H2O)3	 was	
recorded	as	a	polycrystalline	sample	at	room	temperature.	The	
spectrum	 of	 the	 complex	 exhibits	 a	 single	 anisotropic	 broad	
signal.	The	analysis	of	 the	 spectrum	 (Figure	1)	gives	 the	g||	=	
2.1212	and	g 	=	2.0811.	These	values	indicate	that	the	ground	
state	of	Cu(II)	is	predominately	dx2‐y2,	which	supports	a	square	
planar	 structure	 [33,34].	 The	 observed	 g||	 value	 for	 the	
copper(II)	 complex	 is	 less	 than	 2.3,	 thus,	 indicating	 that	 the	
bonds	 between	 the	 organic	 ligand	 and	 copper	 ion	 have	 a	
covalent	 character	 more	 than	 the	 ionic	 one.	 According	 to	
Hathaway	and	Billing	[35,36]	the	G	=	(g||	−	2)/(g 	−	2),	which	
measures	the	exchange	interaction	between	the	copper	centers	
in	 a	 polycrystalline	 solid	has	been	 calculated	 and	 found	 to	be	
less	 than	 4.0.	 This	 value	 indicates	 to	 a	 considerable	 exchange	
interaction	in	solid	complex.	
	
 
	
												Figure	1.	EPR	spectrum	of	Cu(II)	complex.	
3.3.	Thermal	analysis	
	
The	 thermograms	 TGA	 confirms	 the	 amount	 of	 solvent	
inside	 and	 outside	 the	 coordination	 sphere	 and	 gives	 some	
information	 about	 the	 stability	 of	 this	 compound.	 The	
thermograms	 of	 all	 metal	 complexes	 (Figure	 2)	 have	 two	 or	
three	 decomposition	 stages	 from	25	 to	 1000	 °C.	 These	 stages	
involved	 mass	 loss	 of	 ~75	 %.	 TGA	 of	 the	 all	 prepared	
complexes	 show	 first	 stages	 from	 25‐95	 °C	 corresponds	 to	
removal	 of	 water	 molecules	 outside	 the	 coordination	 sphere	
with	 weight	 loss	 calc.	 =	 4.8‐11.6%,	 found	 =	 5.2‐11.0	 %	
indicating	to	1.5‐6.0	molecules	of	water.	The	second	 inflection	
point	stars	at	around	400	°C	with	starting	the	decomposition	of	
the	metal	 complexes	with	weight	 loss	of	about	68‐70%	of	 the	
whole	complex	 leaving	 the	metallic	 residue	for	metal	oxide	or	
metal	carbide.	The	elemental	analysis,	IR	and	electronic	spectra	
with	 thermal	 analysis	 suggest	 the	 complexes	 structures	 given	
in	Scheme	2‐4.	
	
	
Figure	 2.	 TGA	 for	 Cu(II)	 (dark	 brown),	 Co(II)	 (reddish	 brown),	 Ni(II)	
(orange),	Mn(II)	(green)	and	Fe(III)	(buff)	complexes.	
	
	
	
M	=	Co,	X	=	3	and	M=	Ni,	X	=	1.5	
	
Scheme	2	
	
3.4.	Hydrolysis	of	phosphodiester	by	Co(II)	complex		
	
Since	 phosphate	 diesters	 are	 generally	 highly	 resistant	
toward	 the	 hydrolysis	 cleavage,	 therefore,	 catalysts	 reactive	
enough	 to	 hydrolyze	 the	 target	 bonds	 rapidly	 under	
physiological	conditions	represent	a	major	challenge.		
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M	=	Mn,	X	=	6	and	M	=	Cu,	X	=	3.	
	
Scheme	3
	
	
The	 prepared	 complexes	 in	 this	 study	 have	 been	 used	 to	
investigate	 the	hydrolysis	 of	phosphoester	bis‐(p‐nitrophenyl)	
phosphate	 (BNPP)	 in	 an	 aqueous	medium	 and	 under	 normal	
conditions.	 The	 Co(II)	 complex	 showed	 a	 significant	 activity	
while	 the	 other	metal	 complexes	 showed	negligible	 activities.	
In	order	to	establish	the	rate	law	for	the	heterogeneous	bis‐(p‐
nitrophenyl)phosphate	hydrolysis	by	 the	Co(II)	complex	[CoL‐
H(Ac)MeOH].3H2O,	 the	 rate	 is	 further	 determined	 at	 various	
BNPP	 concentration	 values	 (Figure	 3)	 at	 pH	 =	 8.0	 and	 25	 °C.	
The	 rate	 of	 BNPP	 hydrolysis	 is	 found	 to	 be	 linear	 in	 the	
beginning	and	reaching	saturation	at	high	concentration	of	the	
substrate	BNPP,	suggesting	the	possibility	of	a	pre‐equilibrium	
kinetics.	 This	 kinetic	 can	 be	 described	 as	 the	 binding	 of	 the	
substrate	BNPP	(S)	to	the	metal	center	in	the	Co(II)	complex	to	
form	 the	 intermediate	 Co(II)	 complex‐S,	 followed	 by	 the	
conversion	 of	 the	 bound	 BNPP	 into	 products.	 The	 first	 order	
rate	constant	kcat	and	the	maximal	velocity	Vmax	were	found	 to	
be	3.1×10‐4	s‐1	and	0.4	mM/min,	respectively.	The	hydrolysis	of	
BNPP	 with	 different	 concentrations	 of	 the	 catalyst	 [CoL‐H	
(Ac)MeOH].3H2O	 (Figure	 4)	 showed	 linear	 trend	 with	 first	
order	rate	constant	3.1×10‐5	s‐1.	The	auto‐hydrolysis	of	BNPP	is	
extremely	slow	with	rate	constant	Ko	of	1.1×10‐11	s‐1	at	pH	=	7.0	
and	 25	 °C	 [37]	 Thus,	 the	 hydrolysis	 of	 BNPP	 here	 shows	 a	
significant	rate	enhancement	of	2.8	million	fold	with	respect	to	
the	autohydrolysis	of	BNPP	under	the	same	conditions.	
	
	
	
Scheme	4	
	
 
	
Figure	3.	Hydrolysis	of	BNPP	using	Co(II)	complex	in	aqueous	medium	at		
pH	=	8	and	25	°C.	
 
	
Figure	4.	Hydrolysis	of	BNPP	using	different	concentration	of	Co(II)	complex	
in	aqueous	medium	at	pH	=	8	and	25	°C.	
	
4.	Conclusions	
		
The	antibacterial	sulfonamide	was	used	in	the	preparation	
of	 the	 novel	 ligand	 FDMB.	 The	 metal	 complexes	 of	 this	 new	
ligand	were	also	prepared	and	fully	characterized	by	different	
tools	 to	 investigate	 their	 chemical	 structures.	 The	 electronic	
spectral	 data	 showed	 that	 all	 metal	 complexes	 are	 either	
tetrahedral	 or	 square	 planner.	 The	 catalytic	 activity	 of	 the	
prepared	complexes	was	investigated	towards	the	hydrolysis	of	
BNPP	and	the	Co(II)	complex	showed	the	highest	activity.		
	
Acknowledgement	
	
The	 authors	 acknowledge	 the	 Taif	 University	 for	 the	 help	
provided	to	publish	this	manuscript.		
	
References		
	
[1]. Purushottamachar,	 P.;	 Khandelwal,	 A.;	 Vasaitis,	 T.	 S.;	 Bruno,	 R.	 D.;	
Gediya,	 L.	 K.;	Njar,	V.	 C.	O.	Bioorgan.	Med.	Chem.	2008,	16(7),	 3519‐
3529.		
[2]. Stranix,	B.	R.;	Lavallee,	 J.	F.;	 Sevigny,	G.;	Yelle,	 J.;	Perron,	V.;	LeBerre,	
N.;	Herbart,	D.;	Wu	J.	J.	Bioorgan.	Med.	Chem.	Lett.	2006,	16(13),	3459‐
3462.		
[3]. Abbate,	F.;	Casini,	A.;	Owa,	T.;	Scozzafava,	A.;	Supuran,	C.	T.	Bioorgan.	
Med.	Chem.	Lett.	2004,	14(1),	217‐223.		
[4]. Na,	K.;	Bae,	Y.	H.	Pharm.	Res.	2002,	19(5),	681‐688.		
[5]. Weber,	A.;	Casini,	A.;	Heine,	A.;	Kuhn,	D.;	Supuran,	C.	T.;	Scozzafava,	A.;	
Klebe,	G.	J.	Med.	Chem.	2004,	47(3),	550‐557.		
[6]. Blobaum,	A.	L.;	Marnett,	L.	J.	J.	Med.	Chem.	2007,	50(7),	1425‐1441.		
[7]. Ezabadi,	I.	R.;	Camoutsis,	C.;	Zoumpoulakis,	P.;	Geronikaki,	A.;	Sokovic,	
M.;	 Glamocilija,	 J.;	 Ciric,	 A.	Bioorgan.	Med.	Chem.	2008,	16(3),	 1150‐
1161.		
[8]. Sum,	P.	E.;	Ross,	A.	T.;	Petersen,	P.	J.;	Testa,	R.	T.	Bioorgan.	Med.	Chem.	
Lett.	2006,	16(2),	400‐403.		
[9]. Padmanilayam,	 M.;	 Scorneaux,	 B.;	 Dong,	 Y.;	 Chollet,	 J.;	 Matile,	 H.;	
Charman,	S.	A.;	Creek,	D.	J.;	Charman,	W.	N.;	Tomas,	J.	S.;	Scheurer,	C.;	
Wittlin,	S.;	Brun,	R.	Vennerstrom,	J.	L.	Bioorgan.	Med.	Chem.	Lett.	2006,	
16(21),	5542‐5545.		
	
Hanafy	et	al.	/	European	Journal	of	Chemistry	4	(2)	(2013)	157‐161	 161	
 
[10]. Bouchain,	G.;	Leit,	S.;	Frechette,	S.;	Khalil,	E.	A.;	Lavoie,	R.;	Moradei,	O.;	
Woo,	 S.	 H.;	 Fournel,	 M.;	 Yan,	 P.	 T.;	 Kalita,	 A.;	 Trachy‐Bourget,	M.	 C.;	
Beaulieu,	 C.;	 Li,	 Z.;	 Robert,	 M.	 F.;	 MacLeod,	 A.	 R.;	 Besterman,	 J.	 M.;	
Delorme,	D.	J.	Med.	Chem.	2003,	46(5),	820‐830.		
[11]. Banerjee,	M.;	Poddar,	A.;	Mitra,	G.;	Surolia,	A.;	Owa,	T.;	Bhattacharyya,	
B.	J.	Med.	Chem.	2005,	48(2),	547‐555.		
[12]. Inaba,	 T.;	 Tanaka,	 K.;	 Takeno,	 R.;	 Nagaki,	 H.;	 Yoshida,	 C.;	 Takano,	 S.	
Chem.	Pharm.	Bull.	2000,	48(1),	131‐139.		
[13]. Gonzalez,	M.	A.;	Gorman,	D.	B.;	Hamilton,	C.	T.;	Roth,	G.	A.	Org.	Process	
Res.	Dev.	2008,	12(2),	301‐303.		
[14]. Arslan,	T.;	Kandemirli,	F.;	Ebenso,	E.	E.;	Love,	I.;	Alemu,	H.	Corros.	Sci.	
2009,	51(1),	35‐47.		
[15]. El‐Naggar,	M.	M.	Corros.	Sci.	2007,	49(5),	2226‐2236.		
[16]. Yang,	C.	T.;	Moubaraki,	B.;	Murray,	K.	S.;	Ranford,	J.	D.;	Vittal,	J.	J.	Inorg.	
Chem.	2001,	40,	5934‐5941.		
[17]. Reddy,	P.	A.	N.;	Nethaji,	M.;	Chakravarty,	A.	R.	Inorg.	Chim.	Acta	2002,	
337,	450‐458.		
[18]. Dutta,	 S.;	 Mondal,	 S.;	 Chakravorty,	 A.	 Polyhedron	 1995,	 14(11),	 63‐
1168.		
[19]. Sigman,	D.	S.;	Graham,	D.	R.;	Aurora,	V.	D.;	 Stern,	A.	M.	 J.	Biol.	Chem.	
1979,	254,	12269‐12272	 	
[20]. Wang,	M.	Z.;	Meng,	Z.	X.;	Liu,	B.	L.;	Cai,	G.	L.;	Zhang,	C.	L.;	Wang,	X.	Y.	
Inorg.	Chem.	Commun.	2005,	8,	368‐371.		
[21]. Yang,	Y.	C.;	Baker,	J.	A.;	Ward,	J.	R.	Chem.	Rev.	1992,	92,	1729‐1743.		
[22]. Hegg,	E.	L.;	Burstyn,	J.	N.	Coord.	Chem.	Rev.	1998,	173,	133‐165		
[23]. Hanafy,	 A.	 I.;	 Tibbs,	 V.;	 Bisht,	 K.	 S.;	Ming,	 L.	 J.	 J.	 Inorg.	Chemica	Acta	
2005,	358,	1247‐1252.		
[24]. Hanafy,	A.	I.;	Maki,	A.	K.	T.;	Mostafa,	M.	M.;	Trans.	Metal	Chem.	2007,	
32,	960‐966.		
[25]. Hafez,	M.	H.;	Abdallah,	A.	M.;	Wahdan,	T.	M.	A.	Analyst	1991,	116,	663‐
666.		
[26]. Hafez,	M.	H.	Anal.	Lett.	1992,	25(9),	1779‐1796.		
[27]. Lewis,	L.;	Wilkins,	R.	G.	Modern	Coordination	Chemistry,	Interscience,	
New	York,	1960.		
[28]. Nakamoto,	 K.;	 Infrared	 Spectra	 of	 Inorganic	 and	 Coordination	
Compounds,	John	Wiley	and	Sons,	Inc.,	New	York,	1963.		
[29]. Lever,	 A.	 B.	 P.	 Inorganic	 Electronic	 Spectroscopy,	 Elsevier,	
Amsterdam,	1968.		
[30]. Ahamad,	T.;	Nishat,	N.	J.	Appl.	Polym.	Sci.	2008,	107,	2280‐2288.		
[31]. Ribas,	 J.;	 Diaz,	 C.;	 Costa,	 R.;	 Journauv,	 Y.;	 Mathoniere,	 C.;	 Kahn,	 O.;	
Gleizes,	A.	Inorg.	Chem.	1990,	29,	2042‐2047.		
[32]. Fraser,	C.;	Bosnich,	B.	Inorg.	Chem.	1994,	33,	338‐346.		
[33]. Hanafy,	 A.	 I.;	 El‐Bahy,	 Z.	 M.;	 El‐Henawy,	 A.	 A.;	 Faheim,	 A.	 A.	 J.	Mol.	
Catal.	A:	Chem.	2012,	355,	192‐200.		
[34]. Nishat,	N.;	Ahamad,	T.;	Alshehri,	S.	M.;	Parveen,	 S.	Eur.	 J.	Med.	Chem.	
2010,	45,	1287‐1294.		
[35]. Dudley,	R.	J.;	Hathaway,	B.	J.	J.	Chem.	Soc.	1970,	1725‐1728.		
[36]. Hathaway,	B.	J.;	Billing,	D.	E.	Coord.	Chem.	Rev.	1970,	5,	143‐207.		
[37]. Takasaki,	B.	K.;	Chin,	J.	J.	Am.	Chem.	Soc.	1995,	117,	8582‐8585.		
	
	
	
	
	
